nodes	percent_of_prediction	percent_of_DWPC	metapath
Disopyramide—CHRM3—muscle of abdomen—ovarian cancer	0.0449	0.25	CbGeAlD
Disopyramide—KCND2—myometrium—ovarian cancer	0.0187	0.105	CbGeAlD
Disopyramide—KCND2—decidua—ovarian cancer	0.0139	0.0776	CbGeAlD
Disopyramide—KCND3—uterine cervix—ovarian cancer	0.0127	0.071	CbGeAlD
Disopyramide—KCND3—uterus—ovarian cancer	0.0106	0.0591	CbGeAlD
Disopyramide—KCND2—female gonad—ovarian cancer	0.00995	0.0555	CbGeAlD
Disopyramide—KCND2—testis—ovarian cancer	0.00882	0.0492	CbGeAlD
Disopyramide—KCND3—testis—ovarian cancer	0.00769	0.0429	CbGeAlD
Disopyramide—ORM1—endometrium—ovarian cancer	0.00631	0.0352	CbGeAlD
Disopyramide—KCND3—lymph node—ovarian cancer	0.00557	0.0311	CbGeAlD
Disopyramide—ORM1—female reproductive system—ovarian cancer	0.00522	0.0291	CbGeAlD
Disopyramide—SCN5A—vagina—ovarian cancer	0.00517	0.0289	CbGeAlD
Disopyramide—ORM1—bone marrow—ovarian cancer	0.00493	0.0275	CbGeAlD
Disopyramide—CHRM1—female reproductive system—ovarian cancer	0.00443	0.0247	CbGeAlD
Disopyramide—SLC22A1—vagina—ovarian cancer	0.00433	0.0241	CbGeAlD
Disopyramide—CHRM3—female reproductive system—ovarian cancer	0.00397	0.0221	CbGeAlD
Disopyramide—CHRM3—female gonad—ovarian cancer	0.00361	0.0201	CbGeAlD
Disopyramide—CHRM3—testis—ovarian cancer	0.0032	0.0179	CbGeAlD
Disopyramide—ORM1—lymph node—ovarian cancer	0.00306	0.017	CbGeAlD
Disopyramide—CYP3A4—female reproductive system—ovarian cancer	0.00218	0.0122	CbGeAlD
Disopyramide—Neutropenia—Docetaxel—ovarian cancer	0.00204	0.00249	CcSEcCtD
Disopyramide—Hypotension—Vinorelbine—ovarian cancer	0.00203	0.00248	CcSEcCtD
Disopyramide—Pruritus—Chlorambucil—ovarian cancer	0.00202	0.00246	CcSEcCtD
Disopyramide—Urticaria—Topotecan—ovarian cancer	0.00202	0.00246	CcSEcCtD
Disopyramide—Body temperature increased—Topotecan—ovarian cancer	0.00201	0.00245	CcSEcCtD
Disopyramide—Dry eye—Doxorubicin—ovarian cancer	0.00201	0.00244	CcSEcCtD
Disopyramide—Weight increased—Docetaxel—ovarian cancer	0.00199	0.00242	CcSEcCtD
Disopyramide—Coma—Doxorubicin—ovarian cancer	0.00198	0.00242	CcSEcCtD
Disopyramide—Urticaria—Melphalan—ovarian cancer	0.00198	0.00241	CcSEcCtD
Disopyramide—Diarrhoea—Chlorambucil—ovarian cancer	0.00196	0.00238	CcSEcCtD
Disopyramide—Paraesthesia—Vinorelbine—ovarian cancer	0.00195	0.00238	CcSEcCtD
Disopyramide—Dyspnoea—Vinorelbine—ovarian cancer	0.00194	0.00236	CcSEcCtD
Disopyramide—Decreased appetite—Vinorelbine—ovarian cancer	0.00189	0.00231	CcSEcCtD
Disopyramide—Cardiac failure congestive—Epirubicin—ovarian cancer	0.00188	0.00229	CcSEcCtD
Disopyramide—Fatigue—Vinorelbine—ovarian cancer	0.00188	0.00229	CcSEcCtD
Disopyramide—Pain—Vinorelbine—ovarian cancer	0.00186	0.00227	CcSEcCtD
Disopyramide—Constipation—Vinorelbine—ovarian cancer	0.00186	0.00227	CcSEcCtD
Disopyramide—Arrhythmia—Paclitaxel—ovarian cancer	0.00184	0.00224	CcSEcCtD
Disopyramide—Asthenia—Topotecan—ovarian cancer	0.00183	0.00222	CcSEcCtD
Disopyramide—Vomiting—Chlorambucil—ovarian cancer	0.00182	0.00221	CcSEcCtD
Disopyramide—Agranulocytosis—Docetaxel—ovarian cancer	0.00182	0.00221	CcSEcCtD
Disopyramide—Pruritus—Topotecan—ovarian cancer	0.0018	0.00219	CcSEcCtD
Disopyramide—Feeling abnormal—Vinorelbine—ovarian cancer	0.00179	0.00219	CcSEcCtD
Disopyramide—Asthenia—Melphalan—ovarian cancer	0.00179	0.00218	CcSEcCtD
Disopyramide—Flatulence—Paclitaxel—ovarian cancer	0.00177	0.00215	CcSEcCtD
Disopyramide—Pruritus—Melphalan—ovarian cancer	0.00176	0.00215	CcSEcCtD
Disopyramide—Tension—Paclitaxel—ovarian cancer	0.00176	0.00215	CcSEcCtD
Disopyramide—Dysgeusia—Paclitaxel—ovarian cancer	0.00176	0.00214	CcSEcCtD
Disopyramide—Hepatitis—Docetaxel—ovarian cancer	0.00175	0.00213	CcSEcCtD
Disopyramide—Hypoglycaemia—Epirubicin—ovarian cancer	0.00175	0.00213	CcSEcCtD
Disopyramide—Cardiac failure—Epirubicin—ovarian cancer	0.00175	0.00213	CcSEcCtD
Disopyramide—Nervousness—Paclitaxel—ovarian cancer	0.00174	0.00212	CcSEcCtD
Disopyramide—Diarrhoea—Topotecan—ovarian cancer	0.00174	0.00212	CcSEcCtD
Disopyramide—Hypoaesthesia—Docetaxel—ovarian cancer	0.00174	0.00212	CcSEcCtD
Disopyramide—Cardiac failure congestive—Doxorubicin—ovarian cancer	0.00174	0.00212	CcSEcCtD
Disopyramide—Urticaria—Vinorelbine—ovarian cancer	0.00173	0.00211	CcSEcCtD
Disopyramide—Body temperature increased—Vinorelbine—ovarian cancer	0.00172	0.0021	CcSEcCtD
Disopyramide—Diarrhoea—Melphalan—ovarian cancer	0.00171	0.00208	CcSEcCtD
Disopyramide—Diplopia—Epirubicin—ovarian cancer	0.0017	0.00208	CcSEcCtD
Disopyramide—Nausea—Chlorambucil—ovarian cancer	0.0017	0.00207	CcSEcCtD
Disopyramide—Vision blurred—Paclitaxel—ovarian cancer	0.00169	0.00206	CcSEcCtD
Disopyramide—Dizziness—Topotecan—ovarian cancer	0.00168	0.00205	CcSEcCtD
Disopyramide—Ill-defined disorder—Paclitaxel—ovarian cancer	0.00166	0.00203	CcSEcCtD
Disopyramide—Angioedema—Paclitaxel—ovarian cancer	0.00164	0.002	CcSEcCtD
Disopyramide—Cardiac arrest—Epirubicin—ovarian cancer	0.00162	0.00197	CcSEcCtD
Disopyramide—Vomiting—Topotecan—ovarian cancer	0.00162	0.00197	CcSEcCtD
Disopyramide—Malaise—Paclitaxel—ovarian cancer	0.00162	0.00197	CcSEcCtD
Disopyramide—Cardiac failure—Doxorubicin—ovarian cancer	0.00161	0.00197	CcSEcCtD
Disopyramide—Hypoglycaemia—Doxorubicin—ovarian cancer	0.00161	0.00197	CcSEcCtD
Disopyramide—Vertigo—Paclitaxel—ovarian cancer	0.00161	0.00196	CcSEcCtD
Disopyramide—Syncope—Paclitaxel—ovarian cancer	0.00161	0.00196	CcSEcCtD
Disopyramide—Rash—Topotecan—ovarian cancer	0.0016	0.00196	CcSEcCtD
Disopyramide—Dermatitis—Topotecan—ovarian cancer	0.0016	0.00195	CcSEcCtD
Disopyramide—Blood creatinine increased—Epirubicin—ovarian cancer	0.0016	0.00194	CcSEcCtD
Disopyramide—Headache—Topotecan—ovarian cancer	0.00159	0.00194	CcSEcCtD
Disopyramide—Vomiting—Melphalan—ovarian cancer	0.00158	0.00193	CcSEcCtD
Disopyramide—Loss of consciousness—Paclitaxel—ovarian cancer	0.00158	0.00192	CcSEcCtD
Disopyramide—Diplopia—Doxorubicin—ovarian cancer	0.00158	0.00192	CcSEcCtD
Disopyramide—Rash—Melphalan—ovarian cancer	0.00157	0.00191	CcSEcCtD
Disopyramide—Dermatitis—Melphalan—ovarian cancer	0.00157	0.00191	CcSEcCtD
Disopyramide—Asthenia—Vinorelbine—ovarian cancer	0.00156	0.0019	CcSEcCtD
Disopyramide—Arrhythmia—Docetaxel—ovarian cancer	0.00156	0.0019	CcSEcCtD
Disopyramide—Abdominal pain upper—Epirubicin—ovarian cancer	0.00156	0.0019	CcSEcCtD
Disopyramide—Hypokalaemia—Epirubicin—ovarian cancer	0.00155	0.00189	CcSEcCtD
Disopyramide—Pruritus—Vinorelbine—ovarian cancer	0.00154	0.00188	CcSEcCtD
Disopyramide—Chest pain—Paclitaxel—ovarian cancer	0.00153	0.00186	CcSEcCtD
Disopyramide—Nausea—Topotecan—ovarian cancer	0.00151	0.00184	CcSEcCtD
Disopyramide—Discomfort—Paclitaxel—ovarian cancer	0.00151	0.00184	CcSEcCtD
Disopyramide—Muscular weakness—Epirubicin—ovarian cancer	0.0015	0.00183	CcSEcCtD
Disopyramide—Cardiac arrest—Doxorubicin—ovarian cancer	0.0015	0.00183	CcSEcCtD
Disopyramide—Dry mouth—Paclitaxel—ovarian cancer	0.00149	0.00182	CcSEcCtD
Disopyramide—Diarrhoea—Vinorelbine—ovarian cancer	0.00149	0.00181	CcSEcCtD
Disopyramide—Dysgeusia—Docetaxel—ovarian cancer	0.00149	0.00181	CcSEcCtD
Disopyramide—Abdominal distension—Epirubicin—ovarian cancer	0.00148	0.00181	CcSEcCtD
Disopyramide—Nausea—Melphalan—ovarian cancer	0.00148	0.0018	CcSEcCtD
Disopyramide—Confusional state—Paclitaxel—ovarian cancer	0.00148	0.0018	CcSEcCtD
Disopyramide—Blood creatinine increased—Doxorubicin—ovarian cancer	0.00148	0.0018	CcSEcCtD
Disopyramide—Oedema—Paclitaxel—ovarian cancer	0.00146	0.00178	CcSEcCtD
Disopyramide—Shock—Paclitaxel—ovarian cancer	0.00144	0.00176	CcSEcCtD
Disopyramide—Dizziness—Vinorelbine—ovarian cancer	0.00144	0.00175	CcSEcCtD
Disopyramide—Abdominal pain upper—Doxorubicin—ovarian cancer	0.00144	0.00175	CcSEcCtD
Disopyramide—Hypokalaemia—Doxorubicin—ovarian cancer	0.00143	0.00175	CcSEcCtD
Disopyramide—Thrombocytopenia—Paclitaxel—ovarian cancer	0.00143	0.00175	CcSEcCtD
Disopyramide—Skin disorder—Paclitaxel—ovarian cancer	0.00142	0.00173	CcSEcCtD
Disopyramide—Hyperhidrosis—Paclitaxel—ovarian cancer	0.00142	0.00172	CcSEcCtD
Disopyramide—Anorexia—Paclitaxel—ovarian cancer	0.0014	0.0017	CcSEcCtD
Disopyramide—Muscular weakness—Doxorubicin—ovarian cancer	0.00139	0.00169	CcSEcCtD
Disopyramide—Vomiting—Vinorelbine—ovarian cancer	0.00138	0.00169	CcSEcCtD
Disopyramide—Neutropenia—Epirubicin—ovarian cancer	0.00138	0.00168	CcSEcCtD
Disopyramide—Dysuria—Epirubicin—ovarian cancer	0.00138	0.00168	CcSEcCtD
Disopyramide—Rash—Vinorelbine—ovarian cancer	0.00137	0.00167	CcSEcCtD
Disopyramide—Dermatitis—Vinorelbine—ovarian cancer	0.00137	0.00167	CcSEcCtD
Disopyramide—Abdominal distension—Doxorubicin—ovarian cancer	0.00137	0.00167	CcSEcCtD
Disopyramide—Hypotension—Paclitaxel—ovarian cancer	0.00137	0.00167	CcSEcCtD
Disopyramide—Headache—Vinorelbine—ovarian cancer	0.00136	0.00166	CcSEcCtD
Disopyramide—Syncope—Docetaxel—ovarian cancer	0.00136	0.00166	CcSEcCtD
Disopyramide—Pollakiuria—Epirubicin—ovarian cancer	0.00136	0.00166	CcSEcCtD
Disopyramide—Weight increased—Epirubicin—ovarian cancer	0.00134	0.00163	CcSEcCtD
Disopyramide—Loss of consciousness—Docetaxel—ovarian cancer	0.00134	0.00163	CcSEcCtD
Disopyramide—Insomnia—Paclitaxel—ovarian cancer	0.00132	0.00161	CcSEcCtD
Disopyramide—Paraesthesia—Paclitaxel—ovarian cancer	0.00131	0.0016	CcSEcCtD
Disopyramide—Drowsiness—Epirubicin—ovarian cancer	0.00131	0.0016	CcSEcCtD
Disopyramide—Dyspnoea—Paclitaxel—ovarian cancer	0.00131	0.00159	CcSEcCtD
Disopyramide—Somnolence—Paclitaxel—ovarian cancer	0.0013	0.00159	CcSEcCtD
Disopyramide—Chest pain—Docetaxel—ovarian cancer	0.00129	0.00158	CcSEcCtD
Disopyramide—Nausea—Vinorelbine—ovarian cancer	0.00129	0.00158	CcSEcCtD
Disopyramide—Dyspepsia—Paclitaxel—ovarian cancer	0.00129	0.00157	CcSEcCtD
Disopyramide—Dysuria—Doxorubicin—ovarian cancer	0.00127	0.00155	CcSEcCtD
Disopyramide—Neutropenia—Doxorubicin—ovarian cancer	0.00127	0.00155	CcSEcCtD
Disopyramide—Decreased appetite—Paclitaxel—ovarian cancer	0.00127	0.00155	CcSEcCtD
Disopyramide—Dry mouth—Docetaxel—ovarian cancer	0.00127	0.00154	CcSEcCtD
Disopyramide—Fatigue—Paclitaxel—ovarian cancer	0.00126	0.00154	CcSEcCtD
Disopyramide—Pollakiuria—Doxorubicin—ovarian cancer	0.00126	0.00153	CcSEcCtD
Disopyramide—Constipation—Paclitaxel—ovarian cancer	0.00125	0.00153	CcSEcCtD
Disopyramide—Pain—Paclitaxel—ovarian cancer	0.00125	0.00153	CcSEcCtD
Disopyramide—Confusional state—Docetaxel—ovarian cancer	0.00125	0.00152	CcSEcCtD
Disopyramide—Oedema—Docetaxel—ovarian cancer	0.00124	0.00151	CcSEcCtD
Disopyramide—Weight increased—Doxorubicin—ovarian cancer	0.00124	0.00151	CcSEcCtD
Disopyramide—Agranulocytosis—Epirubicin—ovarian cancer	0.00122	0.00149	CcSEcCtD
Disopyramide—Shock—Docetaxel—ovarian cancer	0.00122	0.00149	CcSEcCtD
Disopyramide—Thrombocytopenia—Docetaxel—ovarian cancer	0.00122	0.00148	CcSEcCtD
Disopyramide—Drowsiness—Doxorubicin—ovarian cancer	0.00121	0.00148	CcSEcCtD
Disopyramide—Feeling abnormal—Paclitaxel—ovarian cancer	0.00121	0.00147	CcSEcCtD
Disopyramide—Skin disorder—Docetaxel—ovarian cancer	0.00121	0.00147	CcSEcCtD
Disopyramide—Bradycardia—Epirubicin—ovarian cancer	0.0012	0.00146	CcSEcCtD
Disopyramide—Anorexia—Docetaxel—ovarian cancer	0.00118	0.00144	CcSEcCtD
Disopyramide—Hepatitis—Epirubicin—ovarian cancer	0.00118	0.00144	CcSEcCtD
Disopyramide—Hypoaesthesia—Epirubicin—ovarian cancer	0.00117	0.00143	CcSEcCtD
Disopyramide—Urticaria—Paclitaxel—ovarian cancer	0.00116	0.00142	CcSEcCtD
Disopyramide—Hypotension—Docetaxel—ovarian cancer	0.00116	0.00141	CcSEcCtD
Disopyramide—Body temperature increased—Paclitaxel—ovarian cancer	0.00116	0.00141	CcSEcCtD
Disopyramide—Agranulocytosis—Doxorubicin—ovarian cancer	0.00113	0.00138	CcSEcCtD
Disopyramide—Insomnia—Docetaxel—ovarian cancer	0.00112	0.00137	CcSEcCtD
Disopyramide—Paraesthesia—Docetaxel—ovarian cancer	0.00111	0.00136	CcSEcCtD
Disopyramide—Bradycardia—Doxorubicin—ovarian cancer	0.00111	0.00135	CcSEcCtD
Disopyramide—Dyspnoea—Docetaxel—ovarian cancer	0.00111	0.00135	CcSEcCtD
Disopyramide—Somnolence—Docetaxel—ovarian cancer	0.0011	0.00134	CcSEcCtD
Disopyramide—Dyspepsia—Docetaxel—ovarian cancer	0.00109	0.00133	CcSEcCtD
Disopyramide—Hepatitis—Doxorubicin—ovarian cancer	0.00109	0.00133	CcSEcCtD
Disopyramide—Hypoaesthesia—Doxorubicin—ovarian cancer	0.00108	0.00132	CcSEcCtD
Disopyramide—Decreased appetite—Docetaxel—ovarian cancer	0.00108	0.00131	CcSEcCtD
Disopyramide—Fatigue—Docetaxel—ovarian cancer	0.00107	0.0013	CcSEcCtD
Disopyramide—Constipation—Docetaxel—ovarian cancer	0.00106	0.00129	CcSEcCtD
Disopyramide—Pain—Docetaxel—ovarian cancer	0.00106	0.00129	CcSEcCtD
Disopyramide—Arrhythmia—Epirubicin—ovarian cancer	0.00105	0.00128	CcSEcCtD
Disopyramide—Asthenia—Paclitaxel—ovarian cancer	0.00105	0.00128	CcSEcCtD
Disopyramide—Pruritus—Paclitaxel—ovarian cancer	0.00104	0.00126	CcSEcCtD
Disopyramide—Feeling abnormal—Docetaxel—ovarian cancer	0.00102	0.00125	CcSEcCtD
Disopyramide—Flatulence—Epirubicin—ovarian cancer	0.00101	0.00123	CcSEcCtD
Disopyramide—Tension—Epirubicin—ovarian cancer	0.00101	0.00123	CcSEcCtD
Disopyramide—Dysgeusia—Epirubicin—ovarian cancer	0.001	0.00122	CcSEcCtD
Disopyramide—Diarrhoea—Paclitaxel—ovarian cancer	0.001	0.00122	CcSEcCtD
Disopyramide—Nervousness—Epirubicin—ovarian cancer	0.000996	0.00121	CcSEcCtD
Disopyramide—Body temperature increased—Docetaxel—ovarian cancer	0.000981	0.0012	CcSEcCtD
Disopyramide—Arrhythmia—Doxorubicin—ovarian cancer	0.000974	0.00119	CcSEcCtD
Disopyramide—Dizziness—Paclitaxel—ovarian cancer	0.000968	0.00118	CcSEcCtD
Disopyramide—Vision blurred—Epirubicin—ovarian cancer	0.000967	0.00118	CcSEcCtD
Disopyramide—Ill-defined disorder—Epirubicin—ovarian cancer	0.000952	0.00116	CcSEcCtD
Disopyramide—Flatulence—Doxorubicin—ovarian cancer	0.000935	0.00114	CcSEcCtD
Disopyramide—Tension—Doxorubicin—ovarian cancer	0.000931	0.00113	CcSEcCtD
Disopyramide—Vomiting—Paclitaxel—ovarian cancer	0.000931	0.00113	CcSEcCtD
Disopyramide—Dysgeusia—Doxorubicin—ovarian cancer	0.000929	0.00113	CcSEcCtD
Disopyramide—Malaise—Epirubicin—ovarian cancer	0.000925	0.00113	CcSEcCtD
Disopyramide—Rash—Paclitaxel—ovarian cancer	0.000923	0.00112	CcSEcCtD
Disopyramide—Dermatitis—Paclitaxel—ovarian cancer	0.000922	0.00112	CcSEcCtD
Disopyramide—Nervousness—Doxorubicin—ovarian cancer	0.000922	0.00112	CcSEcCtD
Disopyramide—Vertigo—Epirubicin—ovarian cancer	0.000922	0.00112	CcSEcCtD
Disopyramide—Syncope—Epirubicin—ovarian cancer	0.00092	0.00112	CcSEcCtD
Disopyramide—Headache—Paclitaxel—ovarian cancer	0.000917	0.00112	CcSEcCtD
Disopyramide—Loss of consciousness—Epirubicin—ovarian cancer	0.000902	0.0011	CcSEcCtD
Disopyramide—Vision blurred—Doxorubicin—ovarian cancer	0.000895	0.00109	CcSEcCtD
Disopyramide—Asthenia—Docetaxel—ovarian cancer	0.000891	0.00109	CcSEcCtD
Disopyramide—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000881	0.00107	CcSEcCtD
Disopyramide—Pruritus—Docetaxel—ovarian cancer	0.000878	0.00107	CcSEcCtD
Disopyramide—Chest pain—Epirubicin—ovarian cancer	0.000873	0.00106	CcSEcCtD
Disopyramide—Nausea—Paclitaxel—ovarian cancer	0.00087	0.00106	CcSEcCtD
Disopyramide—Discomfort—Epirubicin—ovarian cancer	0.000863	0.00105	CcSEcCtD
Disopyramide—Malaise—Doxorubicin—ovarian cancer	0.000856	0.00104	CcSEcCtD
Disopyramide—Dry mouth—Epirubicin—ovarian cancer	0.000854	0.00104	CcSEcCtD
Disopyramide—Vertigo—Doxorubicin—ovarian cancer	0.000853	0.00104	CcSEcCtD
Disopyramide—Syncope—Doxorubicin—ovarian cancer	0.000851	0.00104	CcSEcCtD
Disopyramide—Diarrhoea—Docetaxel—ovarian cancer	0.000849	0.00103	CcSEcCtD
Disopyramide—Confusional state—Epirubicin—ovarian cancer	0.000844	0.00103	CcSEcCtD
Disopyramide—Oedema—Epirubicin—ovarian cancer	0.000837	0.00102	CcSEcCtD
Disopyramide—Loss of consciousness—Doxorubicin—ovarian cancer	0.000834	0.00102	CcSEcCtD
Disopyramide—Shock—Epirubicin—ovarian cancer	0.000824	0.001	CcSEcCtD
Disopyramide—Dizziness—Docetaxel—ovarian cancer	0.000821	0.001	CcSEcCtD
Disopyramide—Thrombocytopenia—Epirubicin—ovarian cancer	0.00082	0.000999	CcSEcCtD
Disopyramide—Skin disorder—Epirubicin—ovarian cancer	0.000813	0.000991	CcSEcCtD
Disopyramide—Hyperhidrosis—Epirubicin—ovarian cancer	0.000809	0.000986	CcSEcCtD
Disopyramide—Chest pain—Doxorubicin—ovarian cancer	0.000808	0.000985	CcSEcCtD
Disopyramide—Discomfort—Doxorubicin—ovarian cancer	0.000798	0.000973	CcSEcCtD
Disopyramide—Anorexia—Epirubicin—ovarian cancer	0.000798	0.000972	CcSEcCtD
Disopyramide—Dry mouth—Doxorubicin—ovarian cancer	0.00079	0.000963	CcSEcCtD
Disopyramide—Vomiting—Docetaxel—ovarian cancer	0.000789	0.000962	CcSEcCtD
Disopyramide—Rash—Docetaxel—ovarian cancer	0.000783	0.000954	CcSEcCtD
Disopyramide—Hypotension—Epirubicin—ovarian cancer	0.000782	0.000953	CcSEcCtD
Disopyramide—Dermatitis—Docetaxel—ovarian cancer	0.000782	0.000953	CcSEcCtD
Disopyramide—Confusional state—Doxorubicin—ovarian cancer	0.000781	0.000952	CcSEcCtD
Disopyramide—Headache—Docetaxel—ovarian cancer	0.000778	0.000947	CcSEcCtD
Disopyramide—Oedema—Doxorubicin—ovarian cancer	0.000775	0.000944	CcSEcCtD
Disopyramide—Shock—Doxorubicin—ovarian cancer	0.000762	0.000929	CcSEcCtD
Disopyramide—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000758	0.000924	CcSEcCtD
Disopyramide—Insomnia—Epirubicin—ovarian cancer	0.000757	0.000923	CcSEcCtD
Disopyramide—Skin disorder—Doxorubicin—ovarian cancer	0.000752	0.000917	CcSEcCtD
Disopyramide—Paraesthesia—Epirubicin—ovarian cancer	0.000752	0.000916	CcSEcCtD
Disopyramide—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000749	0.000912	CcSEcCtD
Disopyramide—Dyspnoea—Epirubicin—ovarian cancer	0.000746	0.000909	CcSEcCtD
Disopyramide—Somnolence—Epirubicin—ovarian cancer	0.000744	0.000907	CcSEcCtD
Disopyramide—Anorexia—Doxorubicin—ovarian cancer	0.000738	0.0009	CcSEcCtD
Disopyramide—Nausea—Docetaxel—ovarian cancer	0.000737	0.000898	CcSEcCtD
Disopyramide—Dyspepsia—Epirubicin—ovarian cancer	0.000737	0.000898	CcSEcCtD
Disopyramide—Decreased appetite—Epirubicin—ovarian cancer	0.000728	0.000887	CcSEcCtD
Disopyramide—Hypotension—Doxorubicin—ovarian cancer	0.000724	0.000882	CcSEcCtD
Disopyramide—Fatigue—Epirubicin—ovarian cancer	0.000722	0.000879	CcSEcCtD
Disopyramide—Pain—Epirubicin—ovarian cancer	0.000716	0.000872	CcSEcCtD
Disopyramide—Constipation—Epirubicin—ovarian cancer	0.000716	0.000872	CcSEcCtD
Disopyramide—Insomnia—Doxorubicin—ovarian cancer	0.000701	0.000854	CcSEcCtD
Disopyramide—Paraesthesia—Doxorubicin—ovarian cancer	0.000696	0.000847	CcSEcCtD
Disopyramide—Dyspnoea—Doxorubicin—ovarian cancer	0.000691	0.000841	CcSEcCtD
Disopyramide—Feeling abnormal—Epirubicin—ovarian cancer	0.00069	0.000841	CcSEcCtD
Disopyramide—Somnolence—Doxorubicin—ovarian cancer	0.000689	0.000839	CcSEcCtD
Disopyramide—Dyspepsia—Doxorubicin—ovarian cancer	0.000682	0.000831	CcSEcCtD
Disopyramide—Decreased appetite—Doxorubicin—ovarian cancer	0.000673	0.00082	CcSEcCtD
Disopyramide—Fatigue—Doxorubicin—ovarian cancer	0.000668	0.000814	CcSEcCtD
Disopyramide—Urticaria—Epirubicin—ovarian cancer	0.000665	0.00081	CcSEcCtD
Disopyramide—Constipation—Doxorubicin—ovarian cancer	0.000662	0.000807	CcSEcCtD
Disopyramide—Pain—Doxorubicin—ovarian cancer	0.000662	0.000807	CcSEcCtD
Disopyramide—Body temperature increased—Epirubicin—ovarian cancer	0.000662	0.000806	CcSEcCtD
Disopyramide—Feeling abnormal—Doxorubicin—ovarian cancer	0.000638	0.000778	CcSEcCtD
Disopyramide—Urticaria—Doxorubicin—ovarian cancer	0.000615	0.00075	CcSEcCtD
Disopyramide—Body temperature increased—Doxorubicin—ovarian cancer	0.000612	0.000746	CcSEcCtD
Disopyramide—Asthenia—Epirubicin—ovarian cancer	0.000601	0.000732	CcSEcCtD
Disopyramide—Pruritus—Epirubicin—ovarian cancer	0.000592	0.000722	CcSEcCtD
Disopyramide—Diarrhoea—Epirubicin—ovarian cancer	0.000573	0.000698	CcSEcCtD
Disopyramide—Asthenia—Doxorubicin—ovarian cancer	0.000556	0.000677	CcSEcCtD
Disopyramide—Dizziness—Epirubicin—ovarian cancer	0.000554	0.000675	CcSEcCtD
Disopyramide—Pruritus—Doxorubicin—ovarian cancer	0.000548	0.000668	CcSEcCtD
Disopyramide—Vomiting—Epirubicin—ovarian cancer	0.000532	0.000649	CcSEcCtD
Disopyramide—Diarrhoea—Doxorubicin—ovarian cancer	0.00053	0.000646	CcSEcCtD
Disopyramide—Rash—Epirubicin—ovarian cancer	0.000528	0.000643	CcSEcCtD
Disopyramide—Dermatitis—Epirubicin—ovarian cancer	0.000527	0.000643	CcSEcCtD
Disopyramide—Headache—Epirubicin—ovarian cancer	0.000524	0.000639	CcSEcCtD
Disopyramide—Dizziness—Doxorubicin—ovarian cancer	0.000512	0.000624	CcSEcCtD
Disopyramide—Nausea—Epirubicin—ovarian cancer	0.000497	0.000606	CcSEcCtD
Disopyramide—Vomiting—Doxorubicin—ovarian cancer	0.000493	0.0006	CcSEcCtD
Disopyramide—Rash—Doxorubicin—ovarian cancer	0.000488	0.000595	CcSEcCtD
Disopyramide—Dermatitis—Doxorubicin—ovarian cancer	0.000488	0.000595	CcSEcCtD
Disopyramide—Headache—Doxorubicin—ovarian cancer	0.000485	0.000591	CcSEcCtD
Disopyramide—Nausea—Doxorubicin—ovarian cancer	0.00046	0.000561	CcSEcCtD
